Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
BridgeBio Pharma Inc. logo

BridgeBio Pharma Inc.

Sector: Manufacturing   

Industry: Pharmaceutical Preparation Manufacturing

Optionable: Yes  Market Cap: 4,319 M  90-day average vol: 3,065,309

Previous close: 25.41  Open: 25.41  Bid: 24.73  Ask: 26.61
52 week range    
OGN / 
Last updated: Wednesday 4th October 2023
MarketXLS Rank

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord


BBIO Income Statement

Invalid dateDec-19Dec-20Dec-21
Amortization-3 M
Amortization of intangibles-3 M
Basic EPS from continuing operations-3.9
Basic EPS total-3.9
Basic weighted shares outstanding105 M118 M144 M
Cost of sales3 M
Diluted EPS total-2.48-3.8-3.9
Diluted normalized net income/share-2.48-3.8-3.9
Diluted weighted shares outstanding105 M118 M144 M
Earnings from equity interest-21 M
EarningsFromEquityInterestNetOfTax-21 M
GainOnSaleOfSecurity69 M
GeneralAndAdministrativeExpense94 M146 M
Gross operating profit41 M8 M67 M
Income before tax-289 M-505 M-586 M
Interest income9 M4 M1 M
InterestExpenseNonOperating9 M37 M47 M
MinorityInterests28 M57 M24 M
MiscOtherSpecialCharges-2 M2 M36 M
Net income from total operations-261 M-449 M-563 M
NetIncomeCommonStockholders-261 M-449 M-563 M
NetIncomeContinuousOperations-261 M-449 M-563 M
NetNonOperatingInterestIncomeExpense150000.0-33 M-46 M
Operating income-266 M-474 M-577 M
Operating income before depreciation (EBITDA)-280 M-467 M-534 M
OperatingExpense307 M483 M643 M
Other income net22 M-2 M-36 M
OtherGandA94 M146 M
OtherOperatingExpenses3 M-5 M-5 M
RentAndLandingFees-3 M
Research & development expense210 M337 M451 M
ResearchExpense210 M337 M451 M
SalariesAndWages-21 M-58 M
Selling Gen & administrative expense94 M146 M192 M
SellingAndMarketingExpense146 M192 M
SellingExpense146 M192 M
Total Income available for interest expense (EBIT)-280 M-469 M-540 M
Total common shares outstanding124 M149 M148 M
Total net income-261 M-449 M-563 M
Total ordinary shares162 M162 M162 M
Total revenues41 M8 M70 M
TotalExpenses307 M483 M646 M
TotalRevenue41 M8 M70 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder/CEO of MarketXLS. With over six years of experience, I've helped 2500+ customers implement personalized investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and Templates.
Get started today